Buchumschlag

Improving Power in Randomized Controlled Trials with Time-to-Event Endpoints: A Risk-Free Approach

Fuente: arXiv

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Zhou, Junyi, Liu, Qing, Mo, May, Xia, Amy
Format:	Preprint
Veröffentlicht:	2026
Schlagworte:	Methodology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Prediction Intervals for Interim Events in Randomized Clinical Trials with Time-to-Event Endpoints
von: Ratti, Edoardo, et al.
Veröffentlicht: (2026)

A Unified Approach to Covariate Adjustment for Survival Endpoints in Randomized Clinical Trials
von: Zhang, Zhiwei, et al.
Veröffentlicht: (2025)

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials
von: Maity, Arnab Kumar, et al.
Veröffentlicht: (2024)

On Cluster Randomized Trials with the Desirability of Outcome Ranking (DOOR) Endpoints
von: Shao, Wanying, et al.
Veröffentlicht: (2026)

Utility-Based Dose Optimization Approaches for Multiple-Dose Randomized Trial Designs Accounting for Multiple Endpoints
von: DAngelo, Gina, et al.
Veröffentlicht: (2025)

Modern Causal Inference Approaches to Improve Power for Subgroup Analysis in Randomized Controlled Trials
von: D'Alessandro, Antonio, et al.
Veröffentlicht: (2025)

Study Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions Accounting for Heterogeneous Population
von: Zhang, Hong, et al.
Veröffentlicht: (2023)

Tipping Point Sensitivity Analysis for Missing Data in Time-to-Event Endpoints: Model-Based and Ad hoc Approaches
von: Oodally, Ajmal, et al.
Veröffentlicht: (2025)

Inference for Cumulative Incidences and Treatment Effects in Randomized Controlled Trials with Time-to-Event Outcomes under ICH E9 (R1)
von: Deng, Yuhao, et al.
Veröffentlicht: (2024)

Enhancing Statistical Validity and Power in Hybrid Controlled Trials: A Randomization Inference Approach with Conformal Selective Borrowing
von: Zhu, Ke, et al.
Veröffentlicht: (2024)

Equal Marginal Power for Co-Primary Endpoints
von: Bond, Simon
Veröffentlicht: (2026)

Data-Adaptive and Model-Robust Covariate Adjustment for Time-to-Event Outcomes in Stratified Randomized Trials
von: Kim, Raphael C., et al.
Veröffentlicht: (2026)

Power and Sample Size Calculations for Bayes Factors in two-arm clinical Phase II Trials with binary Endpoints
von: Kelter, Riko
Veröffentlicht: (2026)

Improving the Efficiency of Subgroup Analysis in Randomized Controlled Trials with TMLE
von: Qiu, Sky, et al.
Veröffentlicht: (2026)

Improve Sensitivity Analysis Synthesizing Randomized Clinical Trials With Limited Overlap
von: Jiang, Kuan, et al.
Veröffentlicht: (2024)

Adaptive Selection of the Optimal Strategy to Improve Precision and Power in Randomized Trials
von: Balzer, Laura B., et al.
Veröffentlicht: (2022)

Random Forest for Dynamic Risk Prediction or Recurrent Events: A Pseudo-Observation Approach
von: Loe, Abigail, et al.
Veröffentlicht: (2023)

Bias in Meta-Analytic Modeling of Surrogate Endpoints in Cancer Screening Trials
von: Long, James P., et al.
Veröffentlicht: (2025)

COADVISE: Covariate Adjustment with Variable Selection in Randomized Controlled Trials
von: Liu, Yi, et al.
Veröffentlicht: (2025)

Toward Valid Generative Clinical Trial Data with Survival Endpoints
von: Chassat, Perrine, et al.
Veröffentlicht: (2025)

The FORSS Framework for Sample Size and Power Calculations With Win Statistics for Hierarchical Endpoints
von: Zhang, Baoshan, et al.
Veröffentlicht: (2026)

A Practical Guide to Interpret a Randomized Controlled Trial
von: Tanboga, Ibrahim Halil
Veröffentlicht: (2026)

Model-robust Inference for Seamless II/III Trials with Covariate Adaptive Randomization
von: Yi, Kun, et al.
Veröffentlicht: (2025)

Testing Prioritized Composite Endpoint with Multiple Follow-up Time Examinations
von: Mou, Yunhan, et al.
Veröffentlicht: (2025)

Covariate Selection for Optimizing Balance with an Innovative Adaptive Randomization Approach
von: Guo, Ziqing, et al.
Veröffentlicht: (2024)

Notes on Randomized Controlled Trials for Studying Social Media Harms
von: Felton, Chris
Veröffentlicht: (2026)

Clarifying the Role of the Mantel-Haenszel Risk Difference Estimator in Randomized Clinical Trials
von: Qiu, Xiaoyu, et al.
Veröffentlicht: (2024)

Considerations for the Integration of Randomized Controlled Trials and Real-World Data
von: Qiu, Sky, et al.
Veröffentlicht: (2026)

Correlation Matters! Streamlining the Sample Size Procedure with Composite Time-to-event Endpoints
von: Mou, Yunhan, et al.
Veröffentlicht: (2025)

Selection Bias in Hybrid Randomized Controlled Trials using External Controls: A Simulation Study
von: Chiam, Han Chang, et al.
Veröffentlicht: (2025)

M-learner:A Flexible And Powerful Framework To Study Heterogeneous Treatment Effect In Mediation Model
von: Li, Xingyu, et al.
Veröffentlicht: (2025)

Privacy-preserving Quantile Treatment Effect Estimation for Randomized Controlled Trials
von: Yao, Leon, et al.
Veröffentlicht: (2024)

Covariate Ordered Systematic Sampling as an Improvement to Randomized Controlled Trials
von: Jobson, Deddy, et al.
Veröffentlicht: (2024)

Misclassification of Vaccination Status in Electronic Health Records: A Bayesian Approach in Cluster Randomized Trials
von: Kaplan, Adam, et al.
Veröffentlicht: (2024)

Integrating Randomized Controlled Trial and External Control Data Using Balancing Weights: A Comparison of Estimands and Estimators
von: Wang, Peijin, et al.
Veröffentlicht: (2025)

Complier General Causal Effect in Randomized Controlled Trials with One-Sided Noncompliance
von: Tang, Yin, et al.
Veröffentlicht: (2025)

Non-collapsibility and Built-in Selection Bias of Hazard Ratio in Randomized Controlled Trials
von: Bian, Helen, et al.
Veröffentlicht: (2024)

A General Form of Covariate Adjustment in Randomized Clinical Trials
von: Bannick, Marlena S., et al.
Veröffentlicht: (2023)

Optimal sequential two-stage Bayes Factor Design for two-arm clinical Phase II Trials with binary Endpoints
von: Kelter, Riko
Veröffentlicht: (2026)

Biomarker-Guided Adaptive Enrichment Design with Threshold Detection for Clinical Trials with Time-to-Event Outcome
von: Hua, Kaiyuan, et al.
Veröffentlicht: (2024)